Bosviel et al. demonstrated that genistein and daidzein reduce BRCA1 and BRCA2 promoter methylation, which leads to enhanced protein levels of BRCA1 and BRCA2 in breast cancer cell lines [83]. Here, BRCA2 is linked to breast carcinoma.